Trials / Completed
CompletedNCT04518735
Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)
Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,707 (actual)
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
CORONA is a retrospective, observational, one center study to investigate the clinical evolution (in terms of survival and thromboembolic complications) of patients on chronic treatment with anticoagulants or antiplatelet agents who are admitted to the hospital for COVID-19 compared with patients who do not receive anticoagulants or antiplatelet agents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Antithrombotic Therapy (anticoagulant and/or antiplatelet) before admission for Covid19 | Review of medical records during hospitalization and until day 28 post-entry to compare the clinical outcomes depending on previous antithrombotic therapy |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2020-06-30
- Completion
- 2020-06-30
- First posted
- 2020-08-19
- Last updated
- 2020-08-19
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04518735. Inclusion in this directory is not an endorsement.